913556-82-8Relevant articles and documents
p38 MAP kinase inhibitors. Part 5: Discovery of an orally bio-available and highly efficacious compound based on the 7-amino-naphthyridone scaffold
Natarajan, Swaminathan R.,Liu, Luping,Levorse, Mark,Thompson, James E.,O'Neill, Edward A.,O'Keefe, Stephen J.,Vora, Kalpit A.,Cvetovich, Raymond,Chung, John Y.,Carballo-Jane, Ester,Visco, Denise M.
, p. 5468 - 5471 (2006)
A new sub-class of p38 inhibitors represented by 7-amino-naphthyridone have been discovered. Benchmark compound 16 potently inhibited p38 in vitro, was functionally active, and displayed excellent pharmacokinetic profiles in two animal species. Compound 1